Navigation Links
Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results
Date:6/2/2010

ps, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our uncertainty of product revenues and profits, our ability to generate future revenues, our ability to raise additional capital to continue our drug development programs, the success of our clinical trials, our ability to develop and commercialize products, our ability to obtain required regulatory approvals, our compliance with all Food and Drug Administration regulations, our ability to obtain, maintain and protect intellectual property rights for our products, the risk of litigation regarding our intellectual property rights, our limited sales and manufacturing capabilities, our dependence on third-party manufacturers and value added resellers, our ability to hire and retain skilled personnel, our volatile stock price, and other risks detailed in Repligen's filings with the Securities and Exchange Commission. Repligen assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.


'/>"/>
SOURCE Repligen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
4. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
5. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
9. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
10. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
11. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that the 2015 ... Scientific, have organized a session on nanotechnology for presentation ... Asia’s largest analytical and scientific instruments show, will be ... , The four speakers in this U.S. symposium, “Thinking ... Single Cells” will present their use of nanotechnology to ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 A major ... the biotech start-up dense realm of Boston-Cambridge, is gaining ... able investors. James Sherley, the Director of Boston’s Adult ... the local and national visibility of his company an ... 2013. , In addition to a social media marketing ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 “This kit ... test to screen from 0 to 150 ppb,” said Mark ... is a significant benefit to plant owners and USDA-GIPSA inspection ... and other commodities. Testing can take place in a matter ... only can the plant test the feed and grain before ...
(Date:8/28/2014)...  Next month, executives from clinical trial marketing firm BBK ... with Patient-Centered Clinical Trials 2014 , to be held ... , September 4-5. Patient recruitment experts Bonnie A. Brescia ... will share insights on the benefits of employing an effective ... from media to mobile apps – can be used to ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2
... Surgeons directory service and website at www.TrustedLASIKSurgeons.com ... their vision and find a highly qualified LASIK surgeon. ... is a unique screening process ensuring that only those ... and laser eye surgery in the United States are ...
... Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced ... and high-risk research projects. The Joint Committee of ... has approved funding for two new Reinhart Koselleck ... and Professor Reinhard Drner, an atomic physicist from ...
... animals have been our first line of defense against toxins. ... monitor for poisonous gases. Scientists used fish to test ... though, it can take days to detect a fatal chemical ... miniaturized world of nanotechnology, Tel Aviv University researchers have made ...
Cached Biology Technology:Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 2Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 3Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 4Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 5Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 6Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 7Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons 8Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects 2Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects 3Tiny 'lab-on-a-chip' detects pollutants, disease and biological weapons 2
(Date:9/1/2014)... 10:20 AM EDT) It may be possible to ... unhealthy higher-calorie foods, according to new research by scientists ... on Aging (USDA HNRCA) at Tufts University and at ... Nutrition & Diabetes , a brain scan study ... possible to reverse the addictive power of unhealthy food ...
(Date:9/1/2014)... animals, bats are perfectly adapted to a life without light. ... reflected echoes to measure distance to obstacles or prey. In ... delays. A study carried out by researchers at Technische Universitt ... map dynamically adapts to external factors. , Closer ... in too close to an object, the number of activated ...
(Date:8/31/2014)... new blood test provides a fast and accurate ... proof-of-concept study shows. The newly developed test (TAM-TB ... detect active tuberculosis in children. The test features ... in combination with speed of a blood test. ... the diagnosis of tuberculosis in children, particularly in ...
Breaking Biology News(10 mins):Training your brain to prefer healthy foods 2Zooming in for a safe flight 2New tuberculosis blood test in children is reliable and highly specific 2
... awarded to enhance the development of biopharmaceuticals. , In ... important results, such as industrial-scale production of antibodies, stem ... and commercial scale stem cell therapy. , The ... 2 of the Bioprocessing Research Industry Club (BRIC), a ...
... where a pathogen is transmitted between two individuals in ... a disease will spread. New research has laid ... spreading models, which could allow for more targeted prevention ... study, published in Physical Review Letters , outlines ...
... Calif. , Feb. 5, 2013 DigitalPersona, Inc., ... announced that the DigitalPersona ® Eikon ® Touch ... ® 4500 Reader UID edition USB based single ... and Quality Certification (STQC) Directorate, an office of the ...
Cached Biology News:£6.5M in funding to help manufacture the drugs of the future 2£6.5M in funding to help manufacture the drugs of the future 3£6.5M in funding to help manufacture the drugs of the future 4£6.5M in funding to help manufacture the drugs of the future 5Can you predict how a disease will spread in a population? 2DigitalPersona Fingerprint Readers Receive STQC Certification for UIDAI Program in India 2DigitalPersona Fingerprint Readers Receive STQC Certification for UIDAI Program in India 3
Pim-1 (12H8)...
Ets-1...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
Biology Products: